Levodopa Dose-Limiting Dyskinesias in Treatment of Segawa Disease

J Gordon Millichap

doi:10.15844/pedneurbriefs-26-7-8

Levodopa Dose-Limiting Dyskinesias in Treatment of Segawa Disease

Pediatric Neurology Briefs

Volume 26 (2012): Issue 7

By: J Gordon Millichap

Open Access

|Jul 2012

Abstract

Researchers at the University of Cordoba, and other centers in Spain, Germany and New York report an atypical phenotype of persistent, low-dose levodopa treatment-limiting dyskinesias in 2 members of a family (female child aged 13 years and mother) with prominent brachial dystonia and a novel GCH1 mutation.

References

López-Laso E Beyer K Opladen T Artuch R Saunders-Pullman R Dyskinesias as a limiting factor in the treatment of Segawa disease Pediatr Neurol 2012 Jun 46 6 404 6 10.1016/j.pediatrneurol.2012.03.003 22633640
Open DOI Search in Google Scholar Back to article
Segawa M Nomura Y Nishiyama N Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease) Ann Neurol 2003 54 Suppl 6 S32 45 10.1002/ana.10630 12891652
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-26-7-8 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 55 - 55

Published on: Jul 1, 2012

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Prominent brachial dystonia,

Dyskinesias,

Trihexyphenidyl

© 2012 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 26 (2012): Issue 7